Search

Your search keyword '"Ferrara, J.L.M."' showing total 33 results

Search Constraints

Start Over You searched for: Author "Ferrara, J.L.M." Remove constraint Author: "Ferrara, J.L.M."
33 results on '"Ferrara, J.L.M."'

Search Results

1. Plasma Concentration of Suppressor of Tumorigenicity 2 (ST2), the IL33 Receptor, at Initiation of Graft Versus Host Disease Therapy Predicts Day 28 Response and Day 180 Survival Post-Treatment

2. Reg3α Is a Biomarker of Graft Versus Host Disease of the Gastrointestinal Tract

3. A Three Biomarker Panel at Days 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease

5. Frequency Of CD4+CD25hiFOXP3+ Regulatory T Cells Has Diagnostic And Prognostic Value As A Biomarker For Acute Graft-Versus-Host-Disease

6. TNF-Inhibition With Etanercept For GVHD Prevention In Alternative Donor HCT: Lower TNFR1 Levels Correlate With Better Outcomes

8. Elafin is a Biomarker of Graft Versus Host Disease of the Skin

9. Conditioning with Clofarabine and Busulfan X 4 (CloBu4) For Non-Remission Hematologic Malignancies Including Aml Is Well Tolerated, Facilitates Secure Engraftment, And Exhibits Significant Anti-Tumor Activity

11. 29: Addition of Etanercept to Methylprednisolone as Initial Therapy for Acute GVHD Results in High Response Rates and Improved Survival

13. 30: An integrated genetic-protein analysis of the TNF-family pathway predicts for GVHD

23. Graft-versus-host disease.

24. Persistence of pulmonary pathology and abnormal lung function in IL-3/GM-CSF/IL-5 βc receptor-deficient mice despite correction of alveolar proteinosis after BMT.

28. GM-CSF tumor cell vaccines are more effective than B7-1 vaccines in murine acute myeloid leukemia (AML)

30. Rituximab Treatment of Low Platelet Counts in a Patient with Chronic Graft-versus-Host Disease.

Catalog

Books, media, physical & digital resources